BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Leen Kawas Business Partner Stirs Up More Drama at Athira

  Athira Pharma is circling the wagons and urging shareholders to reject investor Richard Kayne’s calls for a management change.

  April 6, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Esteemed Harvard Researcher Heads to Vertex to Curate Diabetes Portfolio

  Noted Harvard researcher Doug Melton is heading to Vertex Pharmaceuticals to head up investigations into potential transformative treatments for type 1 diabetes.

  April 6, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  FDA Fully Revokes Authorization of GSK and Vir’s Sotrovimab for COVID-19

  The FDA has stated that GSK and Vir’s COVID-19 treatment sotrovimab is no longer authorized to be used for the condition because of its low efficacy against Omicron sub-variant BA.2.

  April 6, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Business

  Global Roundup: Ginkgo/Microba Autoimmune Pact and New Parkinson’s Data

  Biopharma and life sciences organizations from across the globe provide updates on their businesses and pipelines.

  April 6, 2022

   · 

  7 min read

   · 

  Alex Keown
• 

  Drug Development

  Kintor’s Antiviral Demonstrates Broad Protection in Mild to Moderate COVID-19

  The data demonstrated that the drug, when given to the patients for more than seven days, offered a protection rate of 100%.

  April 6, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  New Genomics Technology Could Power Gene Therapy in Oncology

  A team of scientists from Mount Sinai was able to uncover specific tumor microenvironment (TME) regulators using a novel functional genomics technology known as Perturb-map.

  April 6, 2022

   · 

  7 min read

   · 

  Abbey Glasure
• 

  Business

  BioSpace Looks at the Top 8 Biopharma Companies by Net Income

  Here’s a look at the eight most profitable biopharma companies around the world. Profitability, in this case, refers to net income, as opposed to total revenue or sales.

  April 6, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Armed with Robust Data, Citius Will Seek Approval in T-cell lymphoma

  Citius Pharmaceuticals has shared positive topline data from its Phase III clinical trial of I/Ontak. The company plans to file a biologics license application with the FDA later this year.

  April 6, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Business

  Takeda/Evozyne Partnership Headlines Hot Week for Gene Therapy Deals

  Evozyne inked a partnership with Takeda Pharmaceutical to develop next-generation gene therapies for up to four rare disease targets. Continue reading for that and more collaboration news from this week.

  April 6, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  A Win for AI: FDA Approves BioXCel Therapy for Bipolar Disorder and Schizophrenia

  The U.S. Food and Drug Administration (FDA) has approved BioXcel Therapeutics’ Igalmi, a drug designed to reduce agitation episodes in bipolar disorder and schizophrenia patients.

  April 6, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano, M.S.